PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO

May 1, 2011, 00:00
10.1016/j.jval.2011.02.459
https://www.valueinhealthjournal.com/article/S1098-3015(11)00598-5/fulltext
Title : PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00598-5&doi=10.1016/j.jval.2011.02.459
First page : A82
Section Title : Selected Health Care Treatment Studies
Open access? : No
Section Order : 1023
Categories :
Tags :
Regions :
ViH Article Tags :